Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Debt Issued

Aerie Pharmaceuticals Debt Issued Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Debt Issued from 2012 to 2020.
  • Aerie Pharmaceuticals Debt Issued for the quarter ending June 06, 2020 was $8m a 118.39% increase of 10m year over year
  • Aerie Pharmaceuticals Debt Issued for the last 12 months ending June 06, 2020 was $317m a 2.61% increase of 8m year over year
  • Aerie Pharmaceuticals Annual Debt Issued for 2019 was $308m a 60.16% increase of 185m from 2018
  • Aerie Pharmaceuticals Annual Debt Issued for 2014 was $123m a 87.79% increase of 108m from 2013
  • Aerie Pharmaceuticals Annual Debt Issued for 2013 was $15m a 80.00% increase of 12m from 2012
Other Cash Flow Metrics:
  • Aerie Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-43m a 39.56% decrease of -17m year over year
  • Aerie Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-29m a -53.21% increase of 16m year over year
  • Aerie Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $7m
View Chart On Koyfin

Quarterly AERI Debt Issued Data

06/2020$8m
12/2019$0m
09/2019$308m
12/2014$-2m
09/2014$124m
12/2013$0m
09/2013$8m
06/2013$5m
03/2013$3m
12/2012$3m

Annual AERI Debt Issued Data

2019$308m
2014$123m
2013$15m
2012$3m